As previously reported by LawyersandSettlements, the jury in An’s lawsuit (An v. Nieberlein, 24-C12003565) found that although Takeda Pharmaceuticals was negligent in not warning about the risk of bladder cancer, it also found that An’s history as a smoker contributed to his developing cancer. The jury awarded An $1.75 million, but under Maryland law, contributory negligence prevents recovery of that award. So although Takeda was found negligent, a judge threw out the $1.75 million award. An’s family has not said if they will appeal the decision.
The contributory negligence is bad news for An’s family and for anyone else whose actions might have contributed to their development of cancer and live in a state that recognizes contributory negligence. But for those who do not - those who have not committed actions that could have contributed to their cancer - the jury has found that Takeda’s actions were negligent, potentially a positive sign for pending lawsuits.
READ MORE ACTOS SIDE EFFECTS LEGAL NEWS
Takeda faces approximately 3,000 lawsuits concerning the reported link between Actos and bladder cancer. The company has said there is no proof Actos causes bladder cancer, although the FDA has issued a warning about a potential link. Lawsuits against Takeda allege the company downplayed risks associated with the drug.